FierceBiotech

SAGE Therapeutics Announces Positive Top-Line Data in Exploratory Trial of SAGE-547 in Postpartum Depression

Plan to Initiate Placebo-Controlled Trial of SAGE-547 by Year End and Advance Novel Product Candidates for Potential Development CAMBRIDGE, Mass., June 9, 2015 (GLOBE NEWSWIRE) -- SAGE Therapeutics ...
FierceBiotech

SAGE Therapeutics Reports Positive Top-Line Phase 2 Data of SAGE-547 in Patients With Super-Refractory Status Epilepticus

CAMBRIDGE, Mass., Nov. 10, 2014 (GLOBE NEWSWIRE) -- SAGE Therapeutics (SAGE) today announced that in a Phase 1/2 clinical trial of SAGE-547, an allosteric modulator of both synaptic and extra-synaptic ...
Business Wire

Sage Reports Positive Top-line Results from Phase 1 Clinical Program of SAGE-217

CAMBRIDGE, Mass.-- (BUSINESS WIRE)--Sage Therapeutics (NASDAQ:SAGE) today announced positive top-line results from its Phase 1 clinical program of SAGE-217, a novel, internally-developed orally active ...
Business Wire

Sage Therapeutics Reports Positive Top-line Results from Phase 2 Placebo-Controlled Trial of SAGE-217 in Major Depressive Disorder

– SAGE-217 met primary endpoint and provided rapid, profound and durable effects through 2-week treatment period and additional 4-week follow-up – – Well-tolerated and demonstrated highly ...
Accounting Today

Sage Extends ERP Line

Sage North America has released Sage ERP MAS 200 SQL version 4.45, an addition to the Sage enterprise resource planning software lineup that works with Microsoft SQL Server. Sage ERP MAS 200 SQL is a ...